Viracta Therapeutics (VIRX) Total Assets by Year
Viracta Therapeutics Inc closed fiscal year 2023 with $56.7M in total assets, $38.4M in total liabilities and $18.3M in shareholder equity. Total assets fell 40.9% from the prior fiscal year. The table below carries 15 fiscal years, from 2009 to 2023, and the quarters Viracta Therapeutics Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VIRX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY23Filing | FY22Filing | FY21Filing | FY20Filing | FY19Filing | FY18Filing | FY17Filing | FY16Filing | FY15Filing | FY14Filing | FY13Filing | FY12Filing | FY11Filing | FY10Filing | FY09Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $56.7M-40.9% | $96.0M-11.6% | $108.6M+124.7% | $48.3M+161.9% | $18.4M+20.4% | $15.3M-55.4% | $34.3M-20.6% | $43.2M-8.0% | $47.0M+6.2% | $44.2M+9.2% | $40.5M-44.5% | $73.0M+59.2% | $45.9M-16.4% | $54.9M | N/A |
| Total Liabilities | $38.4M+10.0% | $34.9M+146.0% | $14.2M-85.0% | $94.5M+101.8% | $46.8M+50.2% | $31.2M+143.8% | $12.8M-42.4% | $22.2M+13.3% | $19.6M-35.6% | $30.4M-34.8% | $46.7M-23.5% | $61.1M+242.1% | $17.8M+41.5% | $12.6M | N/A |
| Total Equity | $18.3M-70.0% | $61.1M-35.3% | $94.4Mn/m | -$46.2Mn/m | -$28.4Mn/m | -$15.9M-173.6% | $21.5M+2.5% | $21.0M-23.3% | $27.4M+98.5% | $13.8Mn/m | -$6.2M-151.7% | $12.0M-57.3% | $28.0M-33.7% | $42.2M+1950.8% | $2.1M |
VIRX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'24Filing | Q2'24Filing | Q1'24Filing | Q4'23Filing | Q3'23Filing | Q2'23Filing | Q1'23Filing | Q4'22Filing | Q3'22Filing | Q2'22Filing | Q1'22Filing | Q4'21Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $22.0M-66.9% | $31.3M-59.2% | $41.3M-51.8% | $56.7M-40.9% | $66.4M-19.2% | $76.9M-13.8% | $85.8M-12.8% | $96.0M-11.6% | $82.2M-29.5% | $89.2M-30.7% | $98.4M-27.8% | $108.6M+124.7% |
| Total Liabilities | $28.6M-21.6% | $28.7M-20.6% | $30.3M-12.7% | $38.4M+10.0% | $36.4M+153.2% | $36.1M+196.9% | $34.7M+171.2% | $34.9M+146.0% | $14.4M+14.5% | $12.2M+4.9% | $12.8M+11.5% | $14.2M-85.0% |
| Total Equity | -$6.6M-122.1% | $2.7M-93.5% | $11.1M-78.3% | $18.3M-70.0% | $30.0M-55.7% | $40.8M-47.0% | $51.1M-40.3% | $61.1M-35.3% | $67.8M-34.8% | $77.0M-34.2% | $85.6M-31.4% | $94.4Mn/m |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Viracta Therapeutics Inc financials
Frequently Asked Questions
Viracta Therapeutics Inc closed fiscal year 2023 with $56.7M in total assets, $38.4M in total liabilities and $18.3M in shareholder equity.
Viracta Therapeutics Inc (VIRX) total assets fell by 40.9% year over year, from $96.0M to $56.7M in fiscal year 2023.
Viracta Therapeutics Inc (VIRX) reported $22.0M in total assets in Q3 2024. This represents a decrease of 66.9% from the same quarter a year earlier.
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Viracta Therapeutics Inc (VIRX) reported on that line in every period on record.